Advanced Medical Solutions Group (AMS) Competitors

GBX 189.12
+1.52 (+0.81%)
(As of 04:37 AM ET)

AMS vs. TSTL, MXCT, BMK, NIOX, BVXP, PRTC, APH, OXB, HVO, and UPR

Should you be buying Advanced Medical Solutions Group stock or one of its competitors? The main competitors of Advanced Medical Solutions Group include Tristel (TSTL), MaxCyte (MXCT), Benchmark (BMK), NIOX Group (NIOX), Bioventix (BVXP), PureTech Health (PRTC), Alliance Pharma (APH), Oxford Biomedica (OXB), hVIVO (HVO), and Uniphar (UPR). These companies are all part of the "medical" sector.

Advanced Medical Solutions Group vs.

Tristel (LON:TSTL) and Advanced Medical Solutions Group (LON:AMS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£39.49M5.35£6.04M£0.133,423.08
Advanced Medical Solutions Group£126.21M3.23£15.89M£0.072,680.00

Tristel has a net margin of 15.29% compared to Tristel's net margin of 12.59%. Advanced Medical Solutions Group's return on equity of 20.35% beat Tristel's return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.29% 20.35% 9.89%
Advanced Medical Solutions Group 12.59%6.61%4.14%

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 2.9%. Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.1%. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 2,857.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

50.3% of Tristel shares are held by institutional investors. Comparatively, 66.9% of Advanced Medical Solutions Group shares are held by institutional investors. 5.4% of Tristel shares are held by insiders. Comparatively, 2.6% of Advanced Medical Solutions Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Tristel has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, Advanced Medical Solutions Group has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.

In the previous week, Tristel had 3 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 3 mentions for Tristel and 0 mentions for Advanced Medical Solutions Group. Tristel's average media sentiment score of 0.58 beat Advanced Medical Solutions Group's score of 0.34 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Tristel Neutral
Advanced Medical Solutions Group Positive

Advanced Medical Solutions Group received 16 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.70% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
Advanced Medical Solutions GroupOutperform Votes
164
49.70%
Underperform Votes
166
50.30%

Tristel presently has a consensus price target of GBX 390, suggesting a potential downside of 12.36%. Advanced Medical Solutions Group has a consensus price target of GBX 300, suggesting a potential upside of 59.91%. Given Tristel's higher possible upside, analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Tristel beats Advanced Medical Solutions Group on 10 of the 18 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

MetricAdvanced Medical Solutions GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£407.73M£2.64B£4.68B£1.43B
Dividend Yield1.32%1.87%5.49%8.44%
P/E Ratio2,680.00323.81222.211,789.25
Price / Sales3.23176.402,556.28330,590.53
Price / Cash7.87107.4831.4233.57
Price / Book1.653.654.582.52
Net Income£15.89M£90.54M£100.39M£182.88M
7 Day Performance2.29%-3.24%-1.36%0.26%
1 Month Performance0.54%-5.92%-6.21%7.61%
1 Year Performance-22.64%-2.91%9.52%17.93%

Advanced Medical Solutions Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
0.2712 of 5 stars
GBX 470
flat
GBX 390
-17.0%
+33.8%£223.20M£39.49M3,615.38208High Trading Volume
MXCT
MaxCyte
0 of 5 stars
GBX 315
flat
N/A-23.2%£328.01M£41.29M-1,086.21143
BMK
Benchmark
0 of 5 stars
GBX 42.40
-1.2%
N/A+13.1%£313.57M£155.53M-1,413.33823
NIOX
NIOX Group
0.5638 of 5 stars
GBX 65.40
flat
GBX 77
+17.7%
+45.7%£276.48M£36.80M3,270.0092
BVXP
Bioventix
0 of 5 stars
GBX 4,600
+2.2%
N/A+19.6%£240.12M£13.60M2,822.0912Gap Up
PRTC
PureTech Health
0 of 5 stars
GBX 210.50
-1.4%
N/A-3.4%£568.25M£11.74M-1,619.23300
APH
Alliance Pharma
2.9104 of 5 stars
GBX 36.30
-2.6%
GBX 80.75
+122.5%
-42.0%£196.17M£170.05M-3,630.00285
OXB
Oxford Biomedica
0.8224 of 5 stars
GBX 195.20
-3.4%
GBX 498.75
+155.5%
-52.8%£195.12M£119.02M-305.00891
HVO
hVIVO
0 of 5 stars
GBX 27.20
-3.7%
N/A+49.7%£185.06M£60.48M-1.00N/A
UPR
Uniphar
0 of 5 stars
GBX 224
-2.2%
N/A-14.1%£611.57M£2.55B1,600.002,800Gap Up

Related Companies and Tools

This page (LON:AMS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners